` 9686 (Neusoft Xikang Holdings Inc) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

N
9686
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Neusoft Xikang Holdings Inc has underperformed Hang Seng (Hong Kong), delivering a return of -12% compared to the Hang Seng (Hong Kong)'s +29% growth.

Stocks Performance
9686 vs Hang Seng (Hong Kong)

Loading
9686
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
9686 vs Hang Seng (Hong Kong)

Loading
9686
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
9686 vs Hang Seng (Hong Kong)

Loading
9686
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Neusoft Xikang Holdings Inc vs Peers

Hang Seng (Hong Kong)
9686
539112
SLB
RDDT
BKR
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Neusoft Xikang Holdings Inc
Glance View

Market Cap
782.9m HKD
Industry
N/A

Neusoft Xikang Holdings Inc is a CN-based company operating in industry. The company is headquartered in Shanghai, Shanghai and currently employs 1,170 full-time employees. The company went IPO on 2023-09-28. Neusoft Xikang Holdings Inc is a company primarily engaged in the provision of cloud hospital platform and medical services. The firm operates primarily through four business segments. The Cloud Hospital Platform Services segment is mainly engaged in the provision of cloud hospital platform construction services and platform connection services. The Internet Medical Services segment is mainly engaged in the provision of Online hospital services, remote medical services, smart family doctor services and Internet home care services. The Health Management Services segment is principally engaged in the provision of comprehensive health management services and chronic disease management services. The Smart Healthcare Products segment mainly sells smart healthcare products to local governments and primary medical institutions, as well as smart healthcare products to corporations and individuals.

Intrinsic Value
1.02 HKD
Undervaluation 9%
Intrinsic Value
Price
N
Back to Top